Stock TARA PROTARA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Protara Therapeutics, Inc.

Equities

TARA

US74365U1079

Market Closed - Nasdaq
Other stock markets
 01:30:00 15/06/2024 am IST 		5-day change 1st Jan Change
2.57 USD -1.53% Intraday chart for Protara Therapeutics, Inc. -3.75% +37.06%
02/05 Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
30/04 Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROTARA THERAPEUTICS, INC. Stock Protara Therapeutics, Inc.
 5.29Cr - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
ARGENX SE Stock argenx SE
 2.29TCr -
BIONTECH SE Stock BioNTech SE
 2.22TCr -
BEIGENE, LTD. Stock BeiGene, Ltd.
 1.7TCr -
  1. Stock Market
  2. Equities
  3. TARA Stock
  4. Charts Protara Therapeutics, Inc.
  5. Sector Chart